A genomic strategy implemented by researchers at Baylor College of Medicine can efficiently increase the molecular diagnostic rate of undiagnosed diseases. The researchers report in the New England Journal of Medicine that reanalysis of preexisting molecular data, taking into consideration new disease-causing genes and other genetic knowledge that have been identified since the original analysis, resulted in an increase in the diagnostic yield of cases, nearly doubling it in one of the reanalysis cohorts.
* This article was originally published here
